Skip to content
Certificates

D / Recovery and repair

GHK-Cu 50 mg

GHK-Cu is supplied as 50 mg of lyophilised powder in a sealed 2R vial. Every vial is filled, tested and released by lot in our own facility.

  • 50 mgNet quantity
  • 2RPresentation
  • 01Compounds
  • 2 to 8 °CStorage
GHK-Cu 50 mg in its 2R vial, standing on a black plinth against a copper ground
Studio picture of the approved vial. The renders below are the record of the product.
GHK-Cu 50 mg, the sealed 2R vial with its copper label facing forward
GHK-Cu 50 mg

The turn

Six angles from the turntable. The back panel carries the lot field, the barcode and the code that resolves to the certificate.

GHK-Cu on the turntable at 180 degrees
Angle 180 degrees

Turntable render. The lot and the codes printed on the back panel are format specimens, not a lot in supply.

Turn the vial

The vial as it is made: glass, cake, stopper, aluminium crimp, copper cap and the printed label.

Drag to turn. The arrow keys turn it too.

Technical sheet

What the product is, stated as identifiers. Lot values are on the certificate and nowhere else.

ProductGHK-Cu 50 mg
Net quantity50 mg
Product code12

The two digits that open the barcode and the QR path printed on the label.

Presentation2R tubular glass vial, 13 mm crimp
Glass format2R · 3 ml · 13 mm flip-off
KindLyophilised powder, single compound
CompoundGHK-Cu
Compound kindPeptide
CAS number49557-75-7
Molecular formulaC14H24N6O4
PubChem CID73587

Open PubChem CID 73587

SequenceH-Gly-His-Lys-OH
Residues3 residues
Formula varianceCAS and formula refer to the free tripeptide GHK. The record for the copper complex is provisional.
Storage2 to 8 °C, protected from light
UseResearch use only. Not for human consumption.
Lot formatLYT-0000-X

Format shown. Not a lot in supply.

CertificateLook up a lot

The certificate for a lot opens from the lookup once it is published.

How this lot was made

Five steps between the sequence and this sealed vial, each with its control and its record.

  1. 01

    Synthesis

    Sequences are assembled by solid-phase peptide synthesis, residue by residue.

    Step 01 on the process page
  2. 02

    Purification

    Crude peptide is purified by preparative HPLC. Fractions are pooled against the purity specification.

    Step 02 on the process page
  3. 03

    Lyophilisation

    The purified solution is freeze-dried into a stable cake.

    Step 03 on the process page
  4. 04

    Fill and finish

    Vials are filled by mass, stoppered and crimp-sealed with an aluminium cap.

    Step 04 on the process page
  5. 05

    Release testing

    Each lot is tested for HPLC purity and pH, then released with its certificate.

    Step 05 on the process page

Schematic. No lot values are shown.

Lyophiliser chamber with four shelves, a loaded tray of vials and the condenser behind its separating valve.
LyophiliserThe step that defines a lyophilised vial. The purified solution is freeze-dried into the cake in this chamber.
The whole process

Released by lot, with its certificate

A lot of this product is not supplied until it is tested. Release is a decision against a written specification, taken once per lot.

  • The lot is tested for purity by HPLC and for pH.
  • Results are compared against the specification, not against the previous lot.
  • A lot that does not meet the specification is not released.

Each lot is released against a written purity specification. The result for a lot is on its certificate.

Purity is confirmed by an independent third-party laboratory alongside our own release testing.

Look up a lot of GHK-Cu

Enter the lot number printed on the GHK-Cu label.Accepted format LYT-0000-X

Further lot documentation is available to distributors and research organisations on request.

Also in group D

Recovery and repair. The other products indexed beside this one.

Full catalogue

Enquiries

Documentation and distribution enquiries reach the laboratory directly. This site publishes no prices and takes no orders.

Email the laboratory